EANM

The European Association of Nuclear Medicine (EANM) is the umbrella organisation of nuclear medicine in Europe and represents the sector towards the European Institutions. Within this role, the EANM aims at advancing science and education in nuclear medicine for the benefit of public health as well as at promoting and co-ordinating, throughout Europe and beyond, discussion and exchange of ideas and results relating to the diagnosis, treatment, research and prevention of diseases through the use of unsealed radioactive substances and the properties of stable nuclides in medicine. The goal of the EANM is thus to provide a suitable medium for the dissemination and discussion of the latest results in the field of nuclear medicine and related subjects.

The EANM has come a long way since its foundation in 1985; much has been accomplished and the organisation has become highly professional. In the coming years the association will strive to increase further the scientific strength of European nuclear medicine and to publicise its unique investigative and therapeutic benefits.

Møder, nyheder m.m. i relation til EANM



20-10-2016   Referat fra delegatmøde i EANM Barcelona 15.10.2016

Kategori:
Generelt
Dato:
20-10-2016
Emne:
Referat fra delegatmøde i EANM Barcelona 15.10.2016
Beskrivelse
Referat
Links:
Links:
 

02-09-2016   New members to Radiation Protection Committee

Kategori:
Nyheder
Dato:
02-09-2016
Emne:
New members to Radiation Protection Committee
Vedhæftede filer
Beskrivelse
The newly established Radiation Protection Committee is currently looking for three to four new members. Our mission is to promote radiation protection for patients, staff and the environment. Our vision is that for every individual undergoing nuclear medicine diagnostic and therapeutic procedures radiation protection is optimized for patients, staff and the environment. This involves not only the nuclear medicine community but also requires interaction with EU agencies and legislative bodies as well as scientific exchange with the different international organizations responsible for radiation protection. This comprises, but is not limited to ICRP, IAEA, IRPA; EURADOS, MELODI etc. The committee is closely linked to the EANM Dosimetry and Physics Committees via co-memberships and to the other committees via respective liaison members. On average the time needed for this very rewarding committee work is 2 days per month. The candidates we seek shall have expertise in at least two of the following fields: • Dose optimization for staff and the environment • Patient dosimetry in diagnostics • Dose and dose rate dependence of cancer risk • Experience in writing guidance documents concerning radiation protection • Lecturing and/or education experience of radiation protection topics for radionuclide therapy and diagnostics Close links to national or international bodies responsible for radiation protection would be considered favorable. To select the best matching professional, we need to evaluate some more data concerning your career. Please download the evaluation form from your vEANM area (Section „Committee Interest“) and return it together with your CV by September 2, 2016 to Ms Magdalena Schwartz at the EANM Executive Office (m.schwartz@eanm.org). The form can also be obtained from the EANM Executive Office. Please also kindly note that only active EANM members are eligible to be an EANM Committee Member.

03-04-2016   Referat fra delegatmøde i Wien

Kategori:
Nyheder
Dato:
03-04-2016
Emne:
Referat fra delegatmøde i Wien
Beskrivelse
Links:
Links:
 

21-12-2015   Nyhedsbrev fra ENMS præsident.

Kategori:
Nyheder
Dato:
21-12-2015
Emne:
Nyhedsbrev fra ENMS præsident.
Vedhæftede filer
Beskrivelse
Dear Colleagues, It is my great pleasure to provide you with a brief update on the events of the past year and the outlook for the year to come. You will know that this year has witnessed significant organisational changes for the EANM with respect to our facilities and many other matters. These changes have been made bearing in mind that the highest level of professionalisation of our Association is mandatory if we are to maintain and, indeed, further develop our leadership in the field. We are now directly managing the Association, the congress, the educational activities and the quality and research services that are provided by EANM. A major effort has been needed to meet the organisational, legal and taxation requirements, but we are on the right path to complete the transition within the next few months. Let me again underline that we have been able to achieve this thanks to the open and continuous collaboration among Board members and between the Board and the CEOs, Executive Directors and staff. We now have a new office and new staff members, but we shall remain and continue to act as the flagship of Nuclear Medicine in Europe. We have learned a lot from this experience and we can say with some certainty that the EANM will benefit from the changes. The Association is in good financial shape and we aim to ensure sustainability for the years to come. Manpower and finances will always be taken into account when evaluating new projects within the scope of our Association. Accurately budgeted strategic plans will ensure that we are able to provide the best services to our community and get the most from the terrific work undertaken by the EANM committees. Next year we shall have, for the first time, one Board position for the Secretary and Treasurer; this means that we shall revert to a Board with six members. The last “pure” EANM Secretary is Savvas Frangos, and I wish to thank him for his constructive contribution to EANM during the last six years. We shall be issuing a survey to National Delegates and Nuclear Medicine departments very soon. The survey is the result of intensive work by a dedicated task force, with continuous feedback from our National Delegates. We hope that the results will help the whole Nuclear Medicine community to better understand the status of Nuclear Medicine in Europe and, on this basis, to establish an appropriate strategy for future years. The congress in Hamburg was a resounding success from every perspective, and we are brave enough to say that EANM is running the best Nuclear Medicine congress in the world. This success is attributable to the continuous and well-orchestrated work of all the EANM volunteers and, of course, the enthusiasm of the participants. Let me just add that our industrial partners are providing continuous support for our initiatives and our strategy, and this is reflected in the continuous exchange of information that we are having with AIPES. You will no doubt recall that we proposed to circulate a poll in order to choose the congress venues in 2018 and 2021. After a careful, detailed analysis of 49 possible venues, we realised that the technical characteristics of the venue are more important than any other factor and therefore we decided to take the decision within the Board. We shall officially communicate our decision on the 2018 and 2021 venues as soon as the choices have been finalised. The EJNMMI is excelling among the imaging journals and this year has achieved its highest ever impact factor. We recognise the continuous efforts of Ignasi Carrió to ensure that this level of quality of the official EANM journal is maintained. The number of EANM journals is growing and, thanks to a fruitful collaboration with Springer, we now have a family including EJNMMI Research, EJNMMI Physics and EJNMMI Radiopharmacy and Chemistry. This family will give us the opportunity to publish very specific papers in the proper scientific setting. Our Association is always working to develop and expand our fields of interest and is willing to cooperate with other players in the medical field, as reflected in the truly multidisciplinary nature of the EANM. With the intention of further deepening these endeavours, we are now strengthening our collaboration with many other associations and federations. The European Union is supporting initiatives directed at radiation protection of patients and workers, one example being MELODI. We are actively involved in these initiatives, creating the basis for optimised use of ionising radiation when imaging patients with radiopharmaceuticals and computed tomography. You will be aware that we have sat on the Board of the European CanCer Organisation (ECCO) for several years. This year ECCO underwent a major change in its structure in order to increase its political actions in the field of oncology. In November elections were held for the new ECCO Board of Directors and EANM obtained a seat. This position will ensure that we are in the driving seat to guide “oncopolicy” in Europe and that we are able to represent medical imaging and molecular therapy in the world of oncology. We have a consolidated partnership with IAEA, WFNMB, SNMMI, AOFNMB, ANZSNM and other associations working in the field of Nuclear Medicine and, of course, we want to expand our relationship in the clinical arena. We are also in close contact and undertaking collaborations with EORTC, ESTRO and ESO and are embarking on new joint initiatives with EFRS and EACVI, to mention just a few examples. The ESNM is working hard to take educational efforts to the next level, providing the Nuclear Medicine community with high-level education on multimodality imaging and therapy with radiopharmaceuticals. We are developing the programmes and allocating the financial resources for this development and you will be able to appreciate the results in the online courses and the courses in Vienna as well as at our annual congress. To achieve this long-term goal, we need, more than ever before, the full support and expertise of our members. In this context, you might wish to read our comments on the hapless initiative by our colleagues from the ESR when they created the ESHI: http://www.auntminnieeurope.com/index.aspx?sec=sup&sub=mol&pag=dis&ItemID=612341 Last but not least, allow me to mention another ambitious initiative that we are undertaking in partnership with UEMS. Within the framework of the many joint activities that we are running together, we are writing a syllabus on how to perform imaging and therapy with radiopharmaceuticals. This document will identify the educational, organisational and technical requirements for procedures with radiopharmaceuticals and will guide us in the extended domain of our discipline. We always appreciate the liveliness and enthusiasm that characterise our community. Here you have read about the many activities that are running within the EANM and, as always, we shall appreciate any criticisms or suggestions that you might wish to communicate to us. On behalf of the EANM Board, CEOs, Executive Directors and staff, I wish you a Merry Christmas and a Happy New Year. Arturo Chiti
Links:
Links:
 

15-07-2015   EANM letter from the President

Kategori:
Nyheder
Dato:
15-07-2015
Emne:
EANM letter from the President
Vedhæftede filer
Beskrivelse
Dear Colleagues, Advancing EANM to the next level requires a strong vision and concerted effort to realise our shared, long term goals. The Board is committed to modernising the organisational structure of the EANM to safeguard the scientific and educational activities of our Association within a changing legal and tax framework. Recent events have prompted the EANM Board to re-examine its relationship with vereint, the company that has managed the EANM office and congresses since 2001. To protect business continuity, the Board commissioned an urgent review of the EANM office with the help of external legal and tax advisors. This evaluation identified several opportunities to enhance the long term success of our Association. We are in the midst of this complex transition but are keen to keep you informed about the substantial progress that has been made to date. Our priority is to complete the infrastructure changes necessary as speedily as possible and we will provide you with regular updates. The Board is committed to serving the best interests of the EANM membership and will deliver a formal report during the Members’ and the National Delegates’ Assembly in Hamburg, which we urge you to attend. Please feel free to contact me or any of the EANM Board members for further information. As always, we welcome your ideas and comments regarding the future development of our Association and our specialty. Best personal regards, on behalf of the EANM Board Arturo Chiti, President 2015-2016
Links:
Links:
 

21-04-2015   Tumor therapy: Making the right choice

Kategori:
Nyheder
Dato:
21-04-2015
Emne:
Tumor therapy: Making the right choice
Vedhæftede filer
Beskrivelse
EANM PRESS SERVICE: For tumor patients the timely choice of the appropriate therapy is of vital importance. Nuclear medical methods such as PET (positron emission tomography) allow not only for targeting the tumor but also for assessing the treatment outcome soon after therapy onset. This enables doctors to change treatment if necessary and adapt it to the specific conditions and needs of their patients, says Prof. Stefano Fanti, expert of the European Association of Nuclear Medicine (EANM).

06-04-2015   Nyhedsbrev

Kategori:
Nyheder
Dato:
06-04-2015
Emne:
Nyhedsbrev
Vedhæftede filer
Beskrivelse
2016 Millennium Technology Prize | Zoom On Arturo Chiti | EANM and EFRS signed MoU | EANM Marathon weekend | Internal Dosimetry Task Force – Call for members | Upcoming Events

05-03-2015   Nyhedsbrev

Kategori:
Alle
Dato:
05-03-2015
Emne:
Nyhedsbrev
Vedhæftede filer
Beskrivelse
INTERESTED IN THYROID? – SAVE THE DATE | Open call for the Technologist interest group | EANM-EAN Guideline | Fellowship Examination 2015 in Vienna | ICNC 12 | Upcoming Events

03-02-2015   EANM Newsletter Edition 2 |February 2015

Kategori:
Nyheder
Dato:
03-02-2015
Emne:
EANM Newsletter Edition 2 |February 2015
Vedhæftede filer

13-01-2015   EANM Newsletter Edition 1 | January 2015

Kategori:
Nyheder
Dato:
13-01-2015
Emne:
EANM Newsletter Edition 1 | January 2015
Vedhæftede filer

19-12-2014   EANM Letter from the President

Kategori:
Generelt
Dato:
19-12-2014
Emne:
EANM Letter from the President
Vedhæftede filer